Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan · Delayed Price · Currency is TWD 50.00
-1.70 (-3.29%)
At close: Nov 6, 2026
TPEX:7806 Revenue
Gin Hwa Biotech Incorporation had revenue of 145.93M TWD in the quarter ending June 30, 2026, with 7.90% growth. This brings the company's total for the last twelve months to 535.88M, up 5.39% year-over-year. In the year 2025, Gin Hwa Biotech Incorporation had annual revenue of 538.65M with 23.80% growth. That makes Gin Hwa Biotech Incorporation the 34,964th largest company in the world by revenue and 1,814th in Taiwan.
Revenue (ttm)
535.88M
Revenue Growth
+5.39%
P/S Ratio
3.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 538.65M | 103.57M | 23.80% |
| Dec 31, 2024 | 435.08M | 31.53M | 7.81% |
| Dec 31, 2023 | 403.56M | 264.11M | 189.41% |
| Dec 31, 2022 | 139.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.